"Offering Zepbound single-dose vials…through another platform to LillyDirect will help ensure broader availability of ...

Sports marketing offers healthcare brands an alternative channel to reach their audiences and align with the strong brand ...

Shares in ophthalmology specialist Bausch + Lomb (B+L) have lost almost 10% of their value on a report that a joint takeover ...

The result of the NEXUS trial means that the two companies can now press on with their plan to refile for EU approval of the ...

Mulvany – who left BenevolentAI when it listed on the Amsterdam stock exchange in 2022 and retains a sizeable stake in the ...

Apimostinel has a similar mode of action to ketamine and derivatives like Johnson & Johnson's Spravato (esketamine) – ...

Launching a new pharmaceutical product is a high-stakes endeavour. Over the past decade, nearly 40% of launches have fallen ...

Crucially for the Netherlands-based biopharma company, the FDA has said that the composite Unified Huntington's Disease ...

Advance Best-In-Class Treatment Across CNS, Emergency Use Treatments, & Infectious Diseases & Secure Long-Term Funding in ...

The BIOSECURE Act, which will prohibit businesses in the US from contracting with various Chinese firms on national security ...

A 26-year-old man has been charged with murder in connection with the fatal shooting last week of UnitedHealth chief ...

Regeneron will have a tough job taking on AstraZeneca’s big-selling Ultomiris in the market for paroxysmal nocturnal ...